A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes
2017 · BMC Medicine · 50 citations
https://doi.org/10.1186/s12916-017-0929-y
S
Sandra Ortiz‐Cuaran
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
131
Papers
2.9K
Citations
28
h-index
36
i10-index
Sandra Ortiz‐Cuaran is an academic researcher from Université Claude Bernard Lyon 1. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Cancer Genomics and Diagnostics & RNA modifications and cancer. The author has an h-index of 28, co-authored 112 publications.
ORCID: 0000-0003-1152-5681Papers by this author
worksTargeting netrin‐3 in small cell lung cancer and neuroblastoma
2021 · EMBO Molecular Medicine · 32 citations
https://doi.org/10.15252/emmm.202012878
LSD1 modulates the non-canonical integrin β3 signaling pathway in non-small cell lung carcinoma cells
2017 · Scientific Reports · 12 citations
https://doi.org/10.1038/s41598-017-09554-x
Author Correction: LSD1 modulates the non-canonical integrin β3 signaling pathway in non-small cell lung carcinoma cells
2018 · Scientific Reports · 0 citations
https://doi.org/10.1038/s41598-018-31451-0
Data from Characterizing evolutionary dynamics reveals strategies to exhaust the spectrum of subclonal resistance in EGFR-mutant lung cancer
2024 · 0 citations
https://doi.org/10.1158/0008-5472.c.6769301.v2
Table S6 from Characterizing evolutionary dynamics reveals strategies to exhaust the spectrum of subclonal resistance in EGFR-mutant lung cancer
2024 · 0 citations
https://doi.org/10.1158/0008-5472.27028147
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat